Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility

Status Completed

Clinical Trial Summary

During the COVID-19 pandemic, the French Agency of Biomedicine has recommended maintaining fertility preservation for patients requiring immediate oncological treatments exhibiting gonadotoxic effects. However, no study has examined the presence of SARS-CoV-2 in sperm from cancer patients. This study aims therefore to detect the presence of SARS-CoV-2, specifically in the seminal fluid and the spermatozoa fractions of cancer patient semen. The investigators will determine if the virus presence in sperm is associated with its presence in the nasal swabs, COVID symptoms, specific serological profiles and particular oncological pathologies/treatments.

Clinical Trial Description

To perform this, all patient undergoing oncological fertility preservation will be evaluated for COVID-19 symptomatology (fever, cough, headache, myalgia, diarrhea, anosmia, pharyngodynia). In addition, a nasopharyngeal swab for SARS-CoV-2 research by RT- qPCR will be performed on the day of semen collection. On the same day, serological tests will be carried out, and 30 to 50 days after, according to HAS specifications with methods validated by the National Reference Center. Seminal fluid and spermatozoa will be separated by density gradient centrifugation for a posteriori molecular analysis of SARS-CoV-2 presence. Will thus be measured, within the same ejaculate, the concordance between the presence of SARS-CoV-2 in the seminal fluid and in the sperm cells fraction. The investigators will also determine if the virus presence in the sperm is related with : - (i) the presence of SARS-CoV-2 in the nasal swab; - (ii) patient symptomatology; - (iii) a specific serological profile; - (iv) a particular oncological pathology and / or treatment. The investigators may also find out if the presence of the SARS-CoV-2 in semen affects sperm quality. This study will be the first one examining the presence of SARS-CoV-2 in semen from cancer patients. This will guarantee the safety of fertility preservation procedures during the COVID-19 pandemic. ;

Study Design

Related Conditions & MeSH terms

COVID-19
Cryopreservation
Fertility
Sperm Preservation in Oncological Patients

Clinical Trial Details

NCT number	NCT04487639
Study type	Interventional
Source	University Hospital, Clermont-Ferrand
Contact
Status	Completed
Phase	N/A
Start date	July 10, 2020
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT02759705` - Bladder Exstrophy (FIVES FertIlity Vesical Exstrophy Sexuality)
Not yet recruiting	`NCT02534857` - A Study Comparing a Shorter Exposure of Oocyte to Spermatozoa Versus a Standard Incubation on the Live Birth Rate of In-vitro Fertilization Treatment	N/A
Enrolling by invitation	`NCT01803893` - Prognostic Value of PIF Detection in Embryo Culture Media Correlation With Pregnancy Outcome	N/A
Completed	`NCT01888744` - Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist	Phase 4
Terminated	`NCT01173276` - Intrauterine Insemination In HIV-Discordant Couples	N/A
Not yet recruiting	`NCT03680937` - Methods for Fertility Preservation: Impact of Vitrification on in Vitro Matured Oocytes
Completed	`NCT03455062` - Fertility Study of Women Who Received Organ Transplantation	N/A
Completed	`NCT02736214` - Reproductive Life Plan-based Counseling With Men	N/A
Completed	`NCT01895192` - Sperm Morphology by High Magnification in Fertility Men	N/A
Terminated	`NCT01614704` - Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility
Terminated	`NCT01268592` - Fertility Preservation in Female Cancer Patients	N/A
Terminated	`NCT01232972` - Oocyte Cryopreservation	N/A
Completed	`NCT01012596` - Creighton Model Effectiveness, Intentions and Behaviors Assessment (CEIBA)
Completed	`NCT00390754` - Usefulness of Home Pregnancy Testing	N/A
Completed	`NCT00231504` - Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count	Phase 1
Completed	`NCT03345264` - The Find Your PATHS (Pragmatic Assessment of a Tool to Help Survivors) to Sexual Health and Parenthood Study	N/A
Recruiting	`NCT05414812` - Intervening on Women's Health for Rural Young Breast Cancer Survivors	N/A
Active, not recruiting	`NCT02661932` - Fertility Preservation in Breast Cancer Patients	Phase 4
Recruiting	`NCT06172504` - Ejaculation Frequency and Semen Parameters
Recruiting	`NCT02878434` - Fertility Preservation in Young Women With Cancer

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male Oncological Patients ? — FERTICOVID

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms